COMPLEX THERAPY IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED INFERTILITY IN ADDITIONAL REPRODUCTIVE TECHNOLOGIES PROGRAMS
DOI:
https://doi.org/10.11603/2415-8798.2018.4.9814Keywords:
endometriosis, infertility, controlled ovulation stimulation, quality of ooocytesAbstract
Endometriosis is a dishormonal, immunodependent disease characterized by benign, focal growth of tissue with the existing epithelial and stromal elements, which are inherent in endometrial in myometry or other organs of genital system and outside it. The main clinical displays of this disease are persistent pain and infertility in 25–50 % of women.
The aim of the study – to improve the method of endometriosis-associated infertility treatment in programs of assisted reproductive technologies with the use of medicine that improve the quality of oocytes.
Materials and Methods. The study involved 94 women of reproductive age, with infertility and histological-confirmed diagnosis of genital endometriosis. The average age of examined women with endometriosis-associated infertility was (31.9±4.0) years. The average body weight of women was (72.2±4.4) kg. The duration of infertility among examined patients amounted from 3 to 10 years with average value (6.2±1.4) year. Primary infertility is found in 63 patients out of 94 (67 %), secondary in 31 patients (3 %). The algorithm of infertility patients treating was carried out according to orders of Healthcare Ministry of Ukraine No. 787 of 09.09.2013 “On Approving the Procedure of Application of Assisted Reproductive Technologies in Ukraine”. Before the ART program data on preliminary examination and treatment of married couples with the further obligatory standard protocol of examination (OSPE) was carried out.
Results and Discussion. The paper shows efficiency of complex therapy by drugs “FT 500 plus” and “Oligodetrym” in women with infertility associated with genital endometriosis before conducting of controlled ovarian stimulation. The patients were further divided into groups, depending on the operative interventions. Stimulation was carried out using a standard "long" protocol with a- GnRH with the use of HCG trigger. Efficiency estimation of treatment quality was carried out with the use of following parameters: total doze of FSH, duration of stimulation, quantity of follicles with diameter more than 17 mm at the moment of introduction trigger of final follicles maturation, the total efficiency coefficient of obtained oocyte-cumulus complexes at TVP, maturity degree of ooocytes, frequency of degenerative changes in oocytes, percentage of fertilization, embryos yield, number of blastocyst.
Conclusions. Application of modified circuits of COS with adjuvant therapy with the purpose of correction of oxidative abnormalities allows to improve the general response of ovaries to stimulation, also to increase the number of ооocytes, degree of their maturity and quality, the coefficient of fertilization and yield of blastocyst in patients with infertility associated with genital endometriosis.
References
Practice Committee of the American Society for Reproductive Medicine (ASRM). (2006). Endometriosis and Infertility. Fertil Steril,14, S156-60.
Suginami, H., & Yano, K. (2008). An ovum capture inhibitor (OCI) in endometriosis peritoneal fluid: an OCI-related membrane responsible for fimbrial failure of ovum capture. Fertil Steril, 50, 648-653.
Verma, S. (2012). Evidence linked treatment for endometriosis-associated infertility. Apollo Med., 1, 9 (3), 184-192.
Tsoumpou, I., Kyrgiou, M., Gelbaya, T.A., & Nardo, L.G. (2009). The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril., 92 (1), 75-87.
Dong, X., Wang, R., Zheng, Y., Xiong, T., Liao, X., & Huang, B. (2014). Surgical treatment for endometrioma does not increase clinical pregnancy rate or live birth/ongoing pregnancy rate after fresh IVF/ICSI treatment. Am J Transl Res., 15, 6 (2), 163-168.
Benschop, L., Farquhar, C., van der Poel, N., & Heineman, M.J. (2010). Interventions for women with endometrioma prior to assisted reproductive technology. In: Cochrane Database of Systematic Reviews [Internet]. John Wiley & Sons, Ltd; [cited 2017 Jan 16].
Aboulghar, M.A., Mansour, R.T., Serour, G.I., AI-Inany, H.G., & Aboulghar, M.M. (2003). The outcome of in vitro fertilization in advanced endometriosis with previous surgery: a case-controlled study. Am J Obstet Gynecol., 188 (2), 371-375.
Macer, M.L., & Taylor, H.S. (2012). Endometriosis and infertility: a review of the pathogenesis and treatment of endometrio¬sis–associated infertility. Obstet Gynecol Clin North Am., 39 (4), 535-549. doi: 10.1016/j.ogc.2012.10.002.
Ozkan, S., Murk, W., & Arici, A. (2008). Endometriosis and in-fertility: epidemiology and evidence-based treatments. Ann N Y Acad Sci., 1127, 92-100. doi: 10.1196/an¬nals.1434.007
Shafik, A., Ratcliffe, N., & Wright, J.T. (2009). Importance of histological diagnosis in patients with pelvic pain and laparoscopic evidence of endometriosis. Gynae¬col Endosc., (9), 301-304. doi: 10.1046/j.1365- 2508.2000.00366.
Senapati, S., Sammel, M.D., Morse, C., & Barnhart, K.T. (2016). Impact of endometriosis onin vitro fertilization outcomes: an evaluation of the Society for AssistedReproductive Technologies Database. Fertil Steril., 106, 164-171
Dumesic, D.A., Meldrum, D.R., Katz-Jaffe, M.G., Krisher, R.L., & Schoolcraft, W.B. (2015). Oocyteenvironment: follicular fluid and cumulus cells are critical for oocyte health. Fertil Steril., 103, 303-316.
Toya, M., Saito, H., Ohta, N., Saito, T., Kaneko, T., & Hiroi, M. (2000). Moderate and severeendometriosis is associated with alterations in the cell cycle of granulosacells in patients undergoing in vitro fertilization and embryo transfer. Fertil Steril., 73, 344-350
Rizk, B., Turki, R., Lotfy, H., & Ranganathan, S. (2015). Surgery for endometriosis-associated infertility: do we exaggerate the magnitude of effect? Facts Views Vis Obgyn, 7 (2), 109-118.
Bedaiwy, M.A., & Falcone, T. (2003). Peritoneal fluid environment in endometriosis. Clinicopathological implications. Minerva ginecol, 55, 000-000–2476-M.GIN./Review p1-13.
Gromova, O.A., Torshin, I.Yu., Limanova, O.A., Gromov, A.N., & Grishina, T.R. (2013). Sistematicheskiy analiz molekulyarno-fiziologicheskikh effektov mio-inozitla – dannyye molekulyarnoy biologii, eksperementalnoy i klinicheskoy meditsiny [Systematic analysis of the molecular and physiological effects of myo-inositle - data from molecular biology, experimental and clinical medicine.]. Effektivnaya farmakoterapiya v akusherstve i ginekologii – Effective pharmacotherapy in obstetrics and gynecology, 8, 37-43 [in Russian].
Sinha, A., & Gupta, S. (2017). The Role of Antioxidant Supplementation in Endometriosis Therapy. Journal of Gynecology and Women’s Health, 3, 1, 1-3.
Pro zatverdzhennya Poriadku zastosuvannia dopomizhnykh reproduktyvnykh tekhnolohii v Ukraini : nakaz Ministerstva okhorony zdorovia Ukrainy vid 09.09.2013 r. – On Approval of the Procedure for the Use of Assisted Reproductive Technologies in Ukraine: Order of the Ministry of Health of Ukraine dated 09.09.2013
Wang, Q., & Sun, Q.Y. (2007). Evaluation of oocyte quality: morphological, cellular and molecular predictors. Reprod. Fertil. Dev., 19, 1-12.
Coticchio, G., Sereni, E., Serrao, L., Mazzone, S., Iadarola, I., & Borini, A. (2004). What criteria for the definition of oocyte quality? Ann. NY Acad Sci., 1034, 132-144.
David, K., Gardner, D.P., Lane M., Stevens, J., Schlenker, T., & Schoolcraft, W.B. (2000). Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertility and Sterility, 6, (73), 1155-1158.
Downloads
Published
Issue
Section
License
Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
